Early potent protection against heterologous SIVsmE660 challenge following live attenuated SIV vaccination in Mauritian cynomolgus macaques.
<h4>Background</h4>Live attenuated simian immunodeficiency virus (SIV) vaccines represent the most effective means of vaccinating macaques against pathogenic SIV challenge. However, thus far, protection has been demonstrated to be more effective against homologous than heterologous strai...
Guardado en:
Autores principales: | Neil Berry, Claire Ham, Edward T Mee, Nicola J Rose, Giada Mattiuzzo, Adrian Jenkins, Mark Page, William Elsley, Mark Robinson, Deborah Smith, Deborah Ferguson, Greg Towers, Neil Almond, Richard Stebbings |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a64fa4c38d5c4c62935da21688bc9508 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Whole genome sequencing in the search for genes associated with the control of SIV infection in the Mauritian macaque model
por: Marc de Manuel, et al.
Publicado: (2018) -
Allogeneic stem cell transplantation in fully MHC-matched Mauritian cynomolgus macaques recapitulates diverse human clinical outcomes
por: Benjamin J. Burwitz, et al.
Publicado: (2017) -
Adenovirus prime, Env protein boost vaccine protects against neutralization-resistant SIVsmE660 variants in rhesus monkeys
por: Brandon F. Keele, et al.
Publicado: (2017) -
Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19
por: Francisco J. Salguero, et al.
Publicado: (2021) -
Effects of therapeutic vaccination on the control of SIV in rhesus macaques with variable responsiveness to antiretroviral drugs.
por: Hillary Claire Tunggal, et al.
Publicado: (2021)